Adam Perriman | Professor of Bioengineering
University of Bristol

Adam Perriman, Professor of Bioengineering, University of Bristol

Adam Perriman is a Professor of Bioengineering at the School of Cellular and Molecular Medicine, University of Bristol. He is internationally distinguished for his pioneering research on the construction and study of novel synthetic biomolecular systems, and his research interests span the fields of chemistry, biophysics and cell therapies. His contributions to this field of interdisciplinary science led to him being named a Wellcome Trust Frontiers Innovator in 2015, and in 2016, he was awarded the prestigious British Biophysical Society Young Investigator's Award and Medal. In 2019, he was named a UK Research and Innovation Future Leaders Fellow. In 2018, he successfully spun-out the cell therapy technology company CytoSeek, which is supported by investment from venture capitalists, angel investors and Innovate UK.


Conference Day 2 - Wednesday 1st April 2020 @ 13:00

Artificial Membrane Binding Proteins for Next-Generation Cell Therapies

  • A new non-GM methodology for re-engineering the membranes of therapeutic cells
  • Cell augmentation provides hypoxia resistance, tissue homing and adhesion, and extracellular matrix formation
  • Platform technology is facile and can be used to rapidly display any protein on any cell or extracellular vesicle
last published: 04/Jun/20 08:25 GMT

back to speakers